Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation ACICLOVIR Aciclovir 5.3 Antiviral drugs->5.3.2 Herpesvirus infections->5.3.2.1 Herpes simplex and varicella zoster infection 5.3 Antiviral drugs->5.3.2 Herpesvirus infections->5.3.2.1 Herpes simplex and varicella zoster infection->aciclovir Aminoglycosides 5.1 Antibacterial drugs Amoebicides 5.4 Antiprotozoal drugs AMOXICILLIN Amoxicillin Amoxil Ancotil Anthelmintics Antibacterial drugs Antifungal drugs 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.3 Broad-spectrum penicillins 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.3 Broad-spectrum penicillins->amoxicillin 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.3 Broad-spectrum penicillins->amoxicillin 5.2 Antifungal drugs->5.2.5 Other antifungals->flucytosine Antimalarials 5.4 Antiprotozoal drugs Antiprotozoal drugs Antipseudomonal penicillins 5.1 Antibacterial drugs->5.1.1 Penicillins Antituberculosis drugs 5.1 Antibacterial drugs Antiviral drugs Atripla reverse transcriptase inhibitors->tenofovir DISOPROXIL->With efavirenz and emtricitabine
Augmentin 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.3 Broad-spectrum penicillins->co-amoxiclav Recommendation to use 1 x co-amoxiclav 250/125 and 1 x amoxicillin 250 mg in place of 1 x co-amoxiclav 500/125 tablet approved by D& T committee (11/07/05). Benzylpenicillin and phenoxymethylpenicillin 5.1 Antibacterial drugs->5.1.1 Penicillins BENZYLPENICILLIN SODIUM 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.1 Benzylpenicillin and phenoxymethylpenicillin BOCEPREVIR Chronic hepatitis C TA253 http://www.nice.org.uk/ta253 PAH Trust does not comission the service requiring use of this drug. Broad-spectrum penicillins 5.1 Antibacterial drugs->5.1.1 Penicillins CEFALEXIN Cefalexin CEFRADINE CEFUROXIME Cephalosporins Cephalosporins, carbapenems, and other beta-lactams Ceporex Cephalosporins Cephalosporins->CEFALEXIN Cephalosporins Cephalosporins carbapenems, and other beta-lactams 5.1 Antibacterial drugs Cephalosporins->CEFALEXIN Chloroquine 5.4 Antiprotozoal drugs->5.4.1 Antimalarials CHLOROQUINE 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Chloroquine Cidomycin 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->GENTAMICIN See Trust Antibiotic Policy for futher details on clinical use. Please refer to Modified Once Daily Gentamicin regime in adults: PAH Trust Guidelines.
CLARITHROMYCIN 5.1 Antibacterial drugs->5.1.5 Macrolides Clindamycin 5.1 Antibacterial drugs CLINDAMYCIN 5.1 Antibacterial drugs->5.1.6 Clindamycin Clindamycin 5.1 Antibacterial drugs->5.1.6 Clindamycin->CLINDAMYCIN CO-AMOXICLAV 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.3 Broad-spectrum penicillins Recommendation to use 1 x co-amoxiclav 250/125 and 1 x amoxicillin 250 mg in place of 1 x co-amoxiclav 500/125 approved by D& T Committee (11/07/05). Co-amoxiclav 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.3 Broad-spectrum penicillins->co-amoxiclav Recommendation to use 1 x co-amoxiclav 250/125 and 1 x amoxicillin 250 mg in place of 1 x co-amoxiclav 500/125 approved by D&T committee (11/07/05). COLISTIMETHATE SODIUM antibacterials->polymyxins TA276 http://www.nice.org.uk/ta276 Colistimethate sodium antibacterials->polymyxins->colistimethate SODIUM Colobreathe antibacterials->polymyxins->colistimethate SODIUM Copegus 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus->ribavirin This drug is not used by the Trust as we do not provide services requiring its use. Crystapen 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.1 Benzylpenicillin and phenoxymethylpenicillin->benzylpenicillin SODIUM DACLATASVIR Chronic hepatitis C Daklinza Chronic hepatitis C->DACLATASVIR Dalacin C 5.1 Antibacterial drugs->5.1.6 Clindamycin->CLINDAMYCIN Dificlir antibacterials->fidaxomicin->fidaxomicin For treating recurrent Clostridium difficile infection on approval of a consultant microbiologist only. DOXYCYCLINE 5.1 Antibacterial drugs->5.1.3 Tetracyclines See Trust Antibiotic Policy Doxycycline 5.1 Antibacterial drugs->5.1.3 Tetracyclines->DOXYCYCLINE See Trust Antibiotic Policy
Drugs for threadworms 5.5 Anthelmintics ENTECAVIR 5.3 Antiviral drugs->5.3.3 Viral hepatitis->5.3.3.1 Chronic hepatitis B TA153 http://www.nice.org.uk/ta153 Not stocked in pharmacy as PAH does not comission the service requiring use of this drug. Erythrocin 5.1 Antibacterial drugs->5.1.5 Macrolides->ERYTHROMYCIN ERYTHROMYCIN 5.1 Antibacterial drugs->5.1.5 Macrolides Erythromycin 5.1 Antibacterial drugs->5.1.5 Macrolides->ERYTHROMYCIN Erythromycin Ethyl Succinate 5.1 Antibacterial drugs->5.1.5 Macrolides->ERYTHROMYCIN Erythromycin Lactobionate 5.1 Antibacterial drugs->5.1.5 Macrolides->ERYTHROMYCIN FIDAXOMICIN antibacterials->fidaxomicin For treating recurrent Clostridium difficile infection on approval of a consultant microbiologist only. Flagyl 5.1 Antibacterial drugs->5.1.11 Metronidazole and tinidazole->metronidazole FLUCLOXACILLIN 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.2 Penicillinase-resistant penicillins Flucloxacillin 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.2 Penicillinase-resistant penicillins->flucloxacillin FLUCYTOSINE 5.2 Antifungal drugs->5.2.5 Other antifungals Fucidin Fusidic acid antibacterials->fusidic acid->sodium FUSIDATE antibacterials GENTAMICIN 5.1 Antibacterial drugs->5.1.4 Aminoglycosides See Trust Antibiotic Policy for futher details on clinical use. Please refer to Modified Once Daily Gentamicin regime in adults: PAH Trust Guidelines. Gentamicin 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->GENTAMICIN See Trust Antibiotic Policy for futher details on clinical use. Please refer to Modified Once Daily Gentamicin regime in adults: PAH Trust Guidelines. Genticin 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->GENTAMICIN Glycopeptides antibacterials
GRISEOFULVIN 5.2 Antifungal drugs->5.2.5 Other antifungals Griseofulvin 5.2 Antifungal drugs->5.2.5 Other antifungals->griseofulvin HIV infection 5.3 Antiviral drugs Incivo Chronic hepatitis C->TELAPREVIR ISONIAZID drugs Isoniazid drugs->isoniazid ITRACONAZOLE 5.2 Antifungal drugs->5.2.1 Triazole antifungals Keflex Kemicetine Klaricid Lipid formulations Cephalosporins->CEFALEXIN antibacterials->chloramphenicol->chloramphenicol 5.1 Antibacterial drugs->5.1.5 Macrolides->CLARITHROMYCIN 5.2 Antifungal drugs->5.2.3 Polyene antifungals->amphotericin Macrolides 5.1 Antibacterial drugs MEBENDAZOLE 5.5 Anthelmintics->5.5.1 Drugs for threadworms Metrolyl METRONIDAZOLE Metronidazole 5.1 Antibacterial drugs->5.1.11 Metronidazole and tinidazole->metronidazole 5.1 Antibacterial drugs->5.1.11 Metronidazole and tinidazole 5.1 Antibacterial drugs->5.1.11 Metronidazole and tinidazole->metronidazole METRONIDAZOLE 5.4 Antiprotozoal drugs->5.4.2 Amoebicides Metronidazole and tinidazole 5.1 Antibacterial drugs NITROFURANTOIN 5.1 Antibacterial drugs->5.1.13 Urinary-tract infections
Nitrofurantoin Olysio 5.1 Antibacterial drugs->5.1.13 Urinary-tract infections->nitrofurantoin Chronic hepatitis C->SIMEPREVIR OSELTAMIVIR 5.3 Antiviral drugs->5.3.4 Influenza TA168 http://www.nice.org.uk/ta168 OSELTAMIVIR 5.3 Antiviral drugs->5.3.4 Influenza TA158 http://www.nice.org.uk/ta158 Other antifungals 5.2 Antifungal drugs OXYTETRACYCLINE 5.1 Antibacterial drugs->5.1.3 Tetracyclines Oxytetracycline Penicillinase-resistant penicillins 5.1 Antibacterial drugs->5.1.3 Tetracyclines->OXYTETRACYCLINE 5.1 Antibacterial drugs->5.1.1 Penicillins Penicillins 5.1 Antibacterial drugs PHENOXYMETHYLPENICILLIN Phenoxymethylpenicillin 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.1 Benzylpenicillin and phenoxymethylpenicillin 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.1 Benzylpenicillin and phenoxymethylpenicillin->phenoxymethylpenicillin Polyene antifungals 5.2 Antifungal drugs Polymyxins antibacterials Primaquine 5.4 Antiprotozoal drugs->5.4.1 Antimalarials PRIMAQUINE 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Primaquine Proguanil 5.4 Antiprotozoal drugs->5.4.1 Antimalarials PROGUANIL HYDROCHLORIDE PROGUANIL HYDROCHLORIDE WITH ATOVAQUONE 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Proguanil 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Proguanil Quinine 5.4 Antiprotozoal drugs->5.4.1 Antimalarials QUININE 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Quinine
Quinolones 5.1 Antibacterial drugs Respiratory syncytial virus 5.3 Antiviral drugs RIBAVIRIN 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus TA331 http://www.nice.org.uk/ta331 This drug is not used by the Trust as we do not provide services requiring its use. RIBAVIRIN 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus TA200 http://www.nice.org.uk/ta200 This drug is not used by the Trust as we do not provide services requiring its use. RIBAVIRIN 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus TA200 http://www.nice.org.uk/ta200 This drug is not used by the Trust as we do not provide services requiring its use. Rifater drugs->rifampicin->combined preparations Rifaximin antibacterials RIFAXIMIN antibacterials->rifaximin TA337 http://www.nice.org.uk/ta337 SIMEPREVIR Chronic hepatitis C TA331 http://www.nice.org.uk/ta331 SODIUM FUSIDATE antibacterials->fusidic acid SOFOSBUVIR Chronic hepatitis C TA330 http://www.nice.org.uk/ta330 SOFOSBUVIR Chronic hepatitis C TA330 http://www.nice.org.uk/ta330 Sovaldi Chronic hepatitis C->SOFOSBUVIR Sporanox 5.2 Antifungal drugs->5.2.1 Triazole antifungals->itraconazole STREPTOMYCIN drugs Streptomycin Sulfate Sulfonamides and trimethoprim drugs->streptomycin 5.1 Antibacterial drugs Tamiflu 5.3 Antiviral drugs->5.3.4 Influenza->OSELTAMIVIR Targaxan antibacterials->rifaximin->rifaximin
TELAPREVIR Chronic hepatitis C TA252 http://www.nice.org.uk/ta252 NICE TA 252 Hepatitis C (genotype 1) - PAH Trust does not comission the service requiring use of this drug TENOFOVIR DISOPROXIL reverse transcriptase inhibitors TA173 http://www.nice.org.uk/ta173 TETRACYCLINE 5.1 Antibacterial drugs->5.1.3 Tetracyclines Tetracyclines 5.1 Antibacterial drugs TRIMETHOPRIM Truvada 5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim reverse transcriptase inhibitors->tenofovir DISOPROXIL->With emtricitabine Urinary-tract infections 5.1 Antibacterial drugs VALACICLOVIR Valtrex Vermox Victrelis Virazole Viread With efavirenz and emtricitabine With emtricitabine 5.3 Antiviral drugs->5.3.2 Herpesvirus infections->5.3.2.1 Herpes simplex and varicella zoster infection 5.3 Antiviral drugs->5.3.2 Herpesvirus infections->5.3.2.1 Herpes simplex and varicella zoster infection->valaciclovir 5.5 Anthelmintics->5.5.1 Drugs for threadworms->mebendazole Chronic hepatitis C->BOCEPREVIR 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus->ribavirin reverse transcriptase inhibitors->tenofovir DISOPROXIL reverse transcriptase inhibitors->tenofovir DISOPROXIL reverse transcriptase inhibitors->tenofovir DISOPROXIL ZANAMIVIR 5.3 Antiviral drugs->5.3.4 Influenza TA168 http://www.nice.org.uk/ta168
ZANAMIVIR 5.3 Antiviral drugs->5.3.4 Influenza TA158 http://www.nice.org.uk/ta158 Zovirax 5.3 Antiviral drugs->5.3.2 Herpesvirus infections->5.3.2.1 Herpes simplex and varicella zoster infection->aciclovir ABACAVIR reverse transcriptase inhibitors AmBisome 5.2 Antifungal drugs->5.2.3 Polyene antifungals->amphotericin->lipid formulations Liposomal Amphoteracin (Ambisome)to be used in accordance with the febrile neutopenia guideline (DA-005)or as recommended by a haematologist/microbiologist. AMPHOTERICIN 5.2 Antifungal drugs->5.2.3 Polyene antifungals AZITHROMYCIN 5.1 Antibacterial drugs->5.1.5 Macrolides Liposomal Amphoteracin (Ambisome)to be used in accordance with the febrile neutopenia guideline (DA-005)or as recommended by a haematologist/microbiologist. Consultant signature only for Bronchiectasis and Cystic fibrosis patients. Also for DOSH in accordance with guidelines. Azithromycin 5.1 Antibacterial drugs->5.1.5 Macrolides->AZITHROMYCIN Consultant signature only for Bronchiectasis and Cystic fibrosis patients. Also for DOSH in accordance with guidelines. Cancidas 5.2 Antifungal drugs->5.2.4 Echinocandin antifungals->caspofungin Available for second line use on the approval of a consultant microbiologist CASPOFUNGIN 5.2 Antifungal drugs->5.2.4 Echinocandin antifungals Available for second line use on the approval of a consultant microbiologist CEFOTAXIME Cephalosporins For treatment of bacterial meningitis and meningococcal septicaemia. See Trust Antibiotic Policy Cefotaxime Cephalosporins->CEFOTAXIME For treatment of bacterial meningitis and meningococcal septicaemia. See Trust Antibiotic Policy CEFTAZIDIME Cephalosporins To be used in accordance with Febrile Neutropenia Guideline (DA-005). See Trust Antibiotic Policy Ceftazidime Cephalosporins->CEFTAZIDIME To be used in accordance with Febrile Neutropenia Guideline (DA-005). See Trust Antibiotic Policy CEFTRIAXONE Cephalosporins For the treatment of bacterial meningitis, meningococcal septicaemia and treatment of gonorrhoea. See Trust Antibiotic Policy
Ceftriaxone Cephalosporins->CEFTRIAXONE For the treatment of bacterial meningitis, meningococcal septicaemia and treatment of gonorrhoea. See Trust Antibiotic Policy Chloramphenicol antibacterials For bacterial meningitis in patients with a history of penicillin or cephalosporin anaphylaxis. See Trust Antibiotic Guidelines. CHLORAMPHENICOL antibacterials->chloramphenicol For bacterial meningitis in patients with a history of penicillin or cephalosporin anaphylaxis. See Trust Antibiotic Guidelines. CIPROFLOXACIN 5.1 Antibacterial drugs->5.1.12 Quinolones Consultant approval required. Ciprofloxacin 5.1 Antibacterial drugs->5.1.12 Quinolones->CIPROFLOXACIN Consultant approval required. Ciproxin 5.1 Antibacterial drugs->5.1.12 Quinolones->CIPROFLOXACIN Consultant approval required. CO-TRIMOXAZOLE 5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim For treatment and prophylaxis of Pneumocystis carinii pneumonia (PCP). Co-trimoxazole 5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim->co-trimoxazole For treatment and prophylaxis of Pneumocystis carinii pneumonia (PCP). Colomycin antibacterials->polymyxins->colistimethate SODIUM Available on agreement of antimicrobial pharmacist/microbiologist. For aerobic and anaerobic Gram +ve and Gram -ve infections resistant to other treatments Combined preparations drugs->rifampicin as part of combination treatment for TB DEMECLOCYCLINE HYDROCHLORIDE 5.1 Antibacterial drugs->5.1.3 Tetracyclines For inappropriate ADH secretion DIDANOSINE reverse transcriptase inhibitors Diflucan 5.2 Antifungal drugs->5.2.1 Triazole antifungals->fluconazole Consultant signature only unless iused in palliative care in which case a junoir doctor may sign but prescription must be countersigned by MacMillan nurse EFAVIRENZ 5.3 Antiviral drugs->5.3.1 HIV infection->non-nucleoside reverse transcriptase inhibitors Ethambutol drugs->ethambutol HYDROCHLORIDE as part of combination treatment for TB
ETHAMBUTOL HYDROCHLORIDE drugs as part of combination treatment for TB Fasigyn 5.1 Antibacterial drugs->5.1.11 Metronidazole and tinidazole->tinidazole dr prestons signature only FLUCONAZOLE 5.2 Antifungal drugs->5.2.1 Triazole antifungals Consultant signature only unless when used in palliative care when a junior doctor may sign with a counter signature of a MacMillan Nurse Fortum Cephalosporins->CEFTAZIDIME To be used in accordance with Febrile Neutropenia Guideline (DA-005). See Trust Antibiotic Policy Fungizone 5.2 Antifungal drugs->5.2.3 Polyene antifungals->amphotericin Liposomal Amphoteracin (Ambisome)to be used in accordance with the febrile neutopenia guideline (DA-005)or as recommended by a haematologist/microbiologist. IMIPENEM WITH CILASTATIN carbapenems, and other beta-lactams->5.1.2.2 Carbapenems Available on agreement of antimicrobial pharmacist/microbiologist. For aerobic and anaerobic Gram +ve and Gram -ve infections resistant to other treatments e.g. ESBL producing organisms. INDINAVIR 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors Invirase 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors->saquinavir Kefadim Cephalosporins->CEFTAZIDIME To be used in accordance with Febrile Neutropenia Guideline (DA-005). See Trust Antibiotic Policy LAMIVUDINE reverse transcriptase inhibitors LEVOFLOXACIN 5.1 Antibacterial drugs->5.1.12 Quinolones for severe community acquired pneumonia in patients with definite history of penicillin or cephalosporin anaphylaxis Levofloxacin 5.1 Antibacterial drugs->5.1.12 Quinolones->LEVOFLOXACIN for severe community acquired pneumonia in patients with definite history of penicillin or cephalosporin anaphylaxis Linezolid antibacterials Available on agreement of antimicrobial pharmacist/microbiologist. Activity against Gram +ve bacteria including MRSA and VRE. Full blood count should be monitored weekly during treatment. It should not be given with another monoamine oxidase inhibitor (MAOI)or within 2 weeks of stopping another MAOI. LINEZOLID antibacterials->linezolid Available on agreement of antimicrobial pharmacist/microbiologist. Activity against Gram +ve bacteria including MRSA and VRE. Full blood count should be monitored weekly during treatment. It should not be given with another monoamine oxidase inhibitor (MAOI)or within 2 weeks of stopping another MAOI.
LYMECYCLINE 5.1 Antibacterial drugs->5.1.3 Tetracyclines Lymecycline 5.1 Antibacterial drugs->5.1.3 Tetracyclines->LYMECYCLINE Meronem carbapenems, and other beta-lactams->5.1.2.2 Carbapenems->MEROPENEM Available on agreement of antimicrobial pharmacist/microbiologist. For aerobic and anaerobic Gram +ve and Gram -ve infections resistant to other treatments MEROPENEM carbapenems, and other beta-lactams->5.1.2.2 Carbapenems Available on agreement of antimicrobial pharmacist/microbiologist. For aerobic and anaerobic Gram +ve and Gram -ve infections resistant to other treatments NEVIRAPINE 5.3 Antiviral drugs->5.3.1 HIV infection->non-nucleoside reverse transcriptase inhibitors Non-nucleoside reverse transcriptase inhibitors Nucleoside reverse transcriptase inhibitors 5.3 Antiviral drugs->5.3.1 HIV infection 5.3 Antiviral drugs->5.3.1 HIV infection Use by Sexual Health Clinic only PALIVIZUMAB 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus Awaiting guidance on the use of this product from the Trust Chief Executive (D&T minutes 16th September 2002). PIPERACILLIN WITH TAZOBACTAM 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.4 Antipseudomonal penicillins In accordance with the febrile neutropenia guideline (DA-005) and for hospital acquired pneumonia, hepatobiliary sepsis and severe septicaemia in accordance with Treatment of Infection guidelines Piperacillin with tazobactam 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.4 Antipseudomonal penicillins->piperacillin WITH TAZOBACTAM In accordance with the febrile neutropenia guideline (DA-005) and for hospital acquired pneumonia, hepatobiliary sepsis and severe septicaemia in accordance with Treatment of Infection guidelines Primaxin carbapenems, and other beta-lactams->5.1.2.2 Carbapenems->IMIPENEM WITH CILASTATIN Available on agreement of antimicrobial pharmacist/microbiologist. For aerobic and anaerobic Gram +ve and Gram -ve infections resistant to other treatments e.g. ESBL producing organisms. Promixin antibacterials->polymyxins->colistimethate SODIUM Available on agreement of antimicrobial pharmacist/microbiologist. For aerobic and anaerobic Gram +ve and Gram -ve infections resistant to other treatments Protease inhibitors 5.3 Antiviral drugs->5.3.1 HIV infection PYRAZINAMIDE drugs as part of combination treatment for TB Rifadin drugs->rifampicin Legionella infection and as part of combination treatment for TB
RIFAMPICIN drugs Legionella infection and as part of combination treatment for TB Rifampicin drugs->rifampicin Legionella infection and as part of combination treatment for TB Rimactane drugs->rifampicin Legionella infection and as part of combination treatment for TB RITONAVIR 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors Rocephin Cephalosporins->CEFTRIAXONE For the treatment of bacterial meningitis, meningococcal septicaemia and treatment of gonorrhoea. See Trust Antibiotic Policy SAQUINAVIR 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors Septrin 5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim->co-trimoxazole For treatment and prophylaxis of Pneumocystis carinii pneumonia (PCP). STAVUDINE reverse transcriptase inhibitors Synagis 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus->palivizumab Awaiting guidance on the use of this product from the Trust Chief Executive (D&T Committee minute 16th September 2002). Targocid antibacterials->glycopeptides->teicoplanin First line glycopeptide used for MRSA infections and other infections caused by Gram +ve bacteria in accordance with the Treatment of Infection guidelines Tavanic 5.1 Antibacterial drugs->5.1.12 Quinolones->LEVOFLOXACIN for severe community acquired pneumonia in patients with definite history of penicillin or cephalosporin anaphylaxis Tazocin 5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.4 Antipseudomonal penicillins->piperacillin WITH TAZOBACTAM In accordance with the febrile neutropenia guideline (DA-005) and for hospital acquired pneumonia, hepatobiliary sepsis and severe septicaemia in accordance with Treatment of Infection guidelines TEICOPLANIN antibacterials->glycopeptides First line glycopeptide used for MRSA infections and other infections caused by Gram +ve bacteria in accordance with the Treatment of Infection guidelines TERBINAFINE 5.2 Antifungal drugs->5.2.5 Other antifungals For dermatology use only Tetralysal 300 5.1 Antibacterial drugs->5.1.3 Tetracyclines->LYMECYCLINE For dermatology use only
TINIDAZOLE 5.1 Antibacterial drugs->5.1.11 Metronidazole and tinidazole Dr. Preston's signature only TINIDAZOLE 5.4 Antiprotozoal drugs->5.4.2 Amoebicides Dr. Preston\'s signature only Vancocin antibacterials->glycopeptides->vancomycin MRSA infection and other infections caused by Gram +ve bacteria in accordance with the Treatment of Infection guidelines. Requires close monitoring of plasma levels and renal function.oral - treatment of Clostridium difficle Infection. VANCOMYCIN antibacterials->glycopeptides MRSA infection and other infections caused by Gram +ve bacteria in accordance with the Treatment of Infection guidelines. Requires close monitoring of plasma levels and renal function. Oral- treatment of Clostridium difficile infection Vancomycin antibacterials->glycopeptides->vancomycin MRSA infection and other infections caused by Gram +ve bacteria in accordance with the Treatment of Infection guidelines. Requires close monitoring of plasma levels and renal function.. Oral - treatment of Clostridium difficile infection Vfend 5.2 Antifungal drugs->5.2.1 Triazole antifungals->voriconazole Available for second line use on the approval of a consultant microbiologist Viramune 5.3 Antiviral drugs->5.3.1 HIV infection->non-nucleoside reverse transcriptase inhibitors->nevirapine VORICONAZOLE 5.2 Antifungal drugs->5.2.1 Triazole antifungals Available for second line use on the approval of a consultant microbiologist ZIDOVUDINE reverse transcriptase inhibitors Use by Sexual Health Clinic only Zithromax 5.1 Antibacterial drugs->5.1.5 Macrolides->AZITHROMYCIN First line treatment for patients presenting to Department of Sexual Health. Available on consultant signature only for bronciectasis and cystic fibrosis patients.